Reference health
Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study
24/24 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 24 checked references that resolve
resolves10.1093/annonc/mdf172
End points for new agents in induction chemotherapy for locally advanced head and neck cancers
resolves10.3389/fcell.2019.00052
Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy
resolves10.1056/NEJMoa0912217
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
resolves10.1093/jnci/djn011
Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
resolves10.1016/S0140-6736(19)32591-7
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
resolves10.3389/fonc.2020.00268
Current Understanding of the Mechanisms Underlying Immune Evasion From PD-1/PD-L1 Immune Checkpoint Blockade in Head and Neck Cancer
resolves10.1158/0008-5472.CAN-15-1490
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment
resolves10.1593/neo.11980
Modeling Pharmacological Inhibition of Mast Cell Degranulation as a Therapy for Insulinoma
resolves10.1158/2159-8290.CD-15-0827
Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer
resolves10.1158/0008-5472.CAN-14-2852
Ibrutinib Exerts Potent Antifibrotic and Antitumor Activities in Mouse Models of Pancreatic Adenocarcinoma
resolves10.1038/s41389-021-00308-z
Inhibition of Bruton’s tyrosine kinase as a therapeutic strategy for chemoresistant oral squamous cell carcinoma and potential suppression of cancer stemness
resolves10.1016/j.celrep.2017.03.037
Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis
resolves10.1016/bs.mie.2019.05.039
High-dimensional multiplexed immunohistochemical characterization of immune contexture in human cancers
resolves10.1073/pnas.1119238109
Bruton's tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response
resolves10.1371/journal.ppat.1003446
Bruton's Tyrosine Kinase (BTK) and Vav1 Contribute to Dectin1-Dependent Phagocytosis of Candida albicans in Macrophages
resolves10.1038/s41408-018-0136-x
Effect of the BTK inhibitor ibrutinib on macrophage- and γδ T cell-mediated response against Mycobacterium tuberculosis
resolves10.1186/s40425-017-0257-y
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
resolves10.1158/2326-6066.CIR-16-0237
Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
resolves10.1111/liv.13746
Hepatotoxicity of immune checkpoint inhibitors: An evolving picture of risk associated with a vital class of immunotherapy agents
resolves10.1158/0008-5472.CAN-14-3098
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
resolves10.1038/sj.bjc.6605465
Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses
The 2 references without a DOI — listed, not checked
no DOI — not checkedHead and neck squamous cell carcinoma
no DOI — not checked2025112606400543300_bib14
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1158/1078-0432.ccr-21-2547"><img src="https://citestamp.com/citestamped/10.1158/1078-0432.ccr-21-2547/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1158/1078-0432.ccr-21-2547)